Frequently used diagnostic methods, for both primary and recurrent prostate cancer, include screening for elevated concentration of the prostate specific antigen (PSA) in blood and biopsy sampling, along with digital rectal exam, and anatomical imaging. The gene discussed is KLK3; the disease is prostate carcinoma.